The reelection of former President Donald Trump initially pleased investors who had worried about another protracted legal ...
On Feb. 18, in U.S. v. Regeneron Pharmaceuticals, the First Circuit Court of Appeals joined the Sixth Circuit and the Eighth Circuit in holding ...
Key Takeaways - The First Circuit ruled in United States v. Regeneron Pharmaceuticals, Inc., that the government must prove but-for causation ...
With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...
Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback